Documentos de Académico
Documentos de Profesional
Documentos de Cultura
ORIGINAL RESEARCH
Abstract
Objective: To examine the efficacy and feasibility of a multifactorial intervention to increase lifestyle physical activity in nonambulatory persons
with multiple sclerosis (MS) based on wheelchair optimization, propulsion skill/technique training, and behavioral strategies based on social
cognitive theory.
Design: Randomized controlled trial, 3-month postintervention follow-up.
Setting: Home and general community, and university research laboratory.
Participants: Nonambulatory individuals with MS (NZ14; mean age SD, 53.68.7y) were randomly assigned to an intervention group (IG) or
a control group (CG).
Interventions: After baseline testing, the IG participants received custom-fit, ultralightweight manual wheelchairs with propulsion/skills
training, followed by 3 months of at-home use with the custom ultralightweight wheelchair and weekly phone calls to deliver support through a
multifactorial intervention. The CG participants received no training and used their own wheelchairs at home during this time.
Main Outcome Measures: All subjects were assessed at baseline and 3 months later for fatigue (Fatigue Severity Scale), upper extremity strength
(digital handheld dynamometer), and propulsion technique (on a treadmill [0.5m/s] with instrumented wheels). Two 1-week bouts of physical
activity were measured in both groups from home with wrist-worn accelerometry at the beginning (IG and CG in own wheelchairs) and end (IG in
study wheelchair, CG in own) of the 3-month period of home use.
Results: The intervention was well tolerated, and no adverse events were reported. The IG demonstrated increased strength (PZ.008) and a trend
toward less fatigue (PZ.068), both with large effect sizes (d>0.8), as well as reduced application of braking torque during propulsion (PZ.003)
with a moderate/large effect size (dZ.73), compared with the CG.
Conclusions: Findings suggest a 3-month physical activity intervention based on manual wheelchair propulsion and training is safe and feasible
for some wheelchair users living with MS and may produce secondary benefits in strength, fatigue, and propulsion technique.
Archives of Physical Medicine and Rehabilitation 2015;-:------ 2015 by the American Congress of Rehabilitation Medicine
0003-9993/15/$36 - see front matter 2015 by the American Congress of Rehabilitation Medicine
http://dx.doi.org/10.1016/j.apmr.2015.06.011
I.M. Rice et al
Methods
Participants
Participants were recruited through the North American Research
Committee on MS, phone calls to previous research participants,
and local MS Society events. Twenty participants were then
screened over the telephone for the following inclusion criteria:
(1) diagnosis of MS (later confirmed by participants physicians);
(2) full-time wheelchair user (use of power or manual for >40h/
wk and >80% ambulation); (3) aged 18 to 64 years; (4) stable
health status for the past 3 months; and (5) bilateral gross upper
extremity strength of at least 4-/5 (acquired later at University of
Illinois at Urbana-Champaign labs). Exclusion criteria were as
follows: (1) wheelchair athletes; (2) orthopedic upper extremity
impairment; (3) self-reported history of cardiovascular or cardiopulmonary disease; and (4) pressure ulcers. Of those initial 20
interested participants, 6 were excluded (3 did not use a wheelchair full time, and 3 were unable to travel).
Study design/procedures
Overview
The local institutional review board approved all experimentation.
Participants were randomly assigned to either an IG or a CG on a
2:1 ratio to best characterize the IG, but still have data on test
stability and administration from the CG (fig 1). Participants (IG
and CG) visited the university labs 2 times, for baseline (visit 1)
and posttesting (visit 2) (fig 2).
List of abbreviations:
CG
FSS
IG
MS
MWP
PA
RESNA
control group
Fatigue Severity Scale
intervention group
multiple sclerosis
manual wheelchair propulsion
physical activity
Rehabilitation Engineering Society of North America
Intervention group
During visit 1, IG participants were examined for upper limb
strength and fatigue. Next they received seating evaluations to
configure the study wheelchair (ICON A1 wheelchaira) to meet
their needs. Next, baseline propulsion biomechanics were recorded followed by technique/safety training. The IG participants
were then given the ICON for 3 months of home use and
encouraged to incorporate it into their daily lives. Example activities were provided to help them achieve this endeavor. During
home use, wrist-worn accelerometers were sent through the mail
to record two 1-week bouts of PA at the beginning and end of the
3-month period (see fig 2). Bout 1 consisted of activity using their
primary mobility device(s) (not the ICON), while bout 2 recorded
activity with the ICON. Finally, IG participants returned to the lab
3 months after visit 1 for follow-up testing identical to baseline.
Study wheelchair
The ICON A1 wheelchair is a rigid, ultralightweight, aluminumframed manual wheelchair meeting Rehabilitation Engineering
Society of North America (RESNA)/American National Standards
Institute voluntary standards. This chair was selected because it
offered the flexibility to meet the standards set forth by RESNA in
a position paper17 on the application of ultralight manual wheelchairs. These standards include durability, adjustability, customization, and the ability to meet the specific mobility and postural
needs of the intended user. The ICON is fully adjustable (eg,
width, length, footrest height, seat/back angle, center of gravity,
back height) and weighs <25lb with rear suspension (fig 3A and
B). All ICON wheelchairs had 25-in quick release rear wheels
with pneumatic tires and 4-in-diameter front caster wheels. An
external contoured aluminum back supportb was attached for
added postural support, and Varilite seat cushionsc were provided.
Training
Safety and technique training were provided to IG participants by
an occupational therapist and a licensed physical therapist with an
Assistive Technology Professional certification. An instructional
multimedia presentation used previously was presented as well.18
The multimedia presentation guidelines are consistent with the
recommendations published by the Consortium for Spinal Cord
Medicine to prevent upper limb pain and injury.19 Manual
wheelchair users are encouraged to use low-frequency, long and
smooth strokes (large contact angle) during the propulsive phase
to decrease the force exerted at a given velocity.19 Additionally,
subjects are encouraged to match the speed of the handrim on
contact to minimize braking torques that slow the wheel.
Behavioral intervention
Based on social cognitive theory,20 the behavioral intervention
was delivered through weekly phone calls by a physical therapist
to IG participants, during which strategies for initiation and
maintaining PA with the ICON were taught. Such strategies
included self-monitoring, goal setting, planning, optimizing
outcome expectations, enhancing self-efficacy, overcoming barriers, and identifying facilitators.
Wheelchair data logger manipulation check
Only the IG members ICON wheelchairs were equipped with
data loggers to ascertain the 3 months of home use. Additionally,
the data logger allowed researchers to determine whether wrist
accelerometer vector counts accumulated during the second
1-week period of home use resulted from ICON use or their own
www.archives-pmr.org
Fig 1
www.archives-pmr.org
I.M. Rice et al
Fig 2
Instruments/measures
Wheelchair propulsion testing
Propulsion testing was performed on a motorized wheelchair
treadmill at a target speed of 0.5m/s.21 Two 25-inch-diameter
SmartWheelse were used to record the 3-dimensional forces and
moments applied to the wheelchair handrim at a sampling frequency of 240Hz. Peak resultant force (N), contact angle (degrees), stroke frequency (strokes/s), and braking torque (N) were
calculated with SmartWheel commercial software.e These variables were selected because of their association with the development of upper extremity pain and injury. Specifically, an
Fig 3 Study wheelchair (ICON) adjustability versus hospital (depot) style wheelchair. (A) ICON: rearward center of gravity configuration (easier
to propel), greater seat angle, low floor-to-seat height. (B) ICON: forward center of gravity configuration, level seat angle, greater floor-to-seat
height. (C) Depot wheelchair: most common wheelchair used by persons with MS, heavy (>36lb), and nonadjustable. Used with permission from
Icon Wheelchairs, Inc.
www.archives-pmr.org
Statistical analysis
All analyses were performed in SPSS version 22.h Differences in
demographic/clinical characteristics were examined using
independent-samples t tests for continuous variables and chi-square
analyses for categorical variables. To examine the effects of the
intervention on outcome variables (muscle strength, fatigue, wrist
accelerometer data), we performed 2-by-2 (group-by-time) mixedfactor analyses of variance. A repeated-measures mixed analysis of
variance was used to examine wheelchair propulsion metrics.
Because of multiple comparisons, a Bonferroni correction was performed to control for an inflated type I error where the alpha level
used to judge statistical significance was set to .0125 (.05/4). Because
of the small sample size, emphasis was placed on calculating effect
sizes per outcome measure as suggested by Rutledge and Loh.29 Even
small effect sizes can have important clinical implications and may
be a more accurate measure of the result of the experimental
manipulation when the sample size is small.29,30 Effect size (d )
associated with the intervention was calculated using Cohens
www.archives-pmr.org
5
Table 1
Demographic characteristics
Characteristics
CG (nZ5)
IG (nZ9)
Age (y)
Sex (M/F)
Time with diagnosis (y)
Type of MS
SP
RR
PP
540.4
1/4
17.68.5
53.311.1
3/6
13.28.9
2
2
1
4
3
2
d (difference in mean scores over time divided by pooled SD) and was
interpreted as small (d0.2), moderate (d w0.5), and large (d0.8).
Results
Demographic characteristics
Demographic characteristics are presented in table 1. Clinically,
participants reported having relapsing-remitting (nZ5), secondary
progressive (nZ6), and primary progressive (nZ3) MS. After
randomization, age, years with diagnosis, sex, and disease type
were not significantly different between groups ([t12Z0.1, PZ.8],
[t12Z0.8, PZ.3], [c21Z.28, PZ.545], and [c22Z.062, PZ.97],
respectively).
Because of equipment malfunction and participant preferences
not to transfer, some data were lost. Two CG participants were
reluctant to transfer into the ICON and therefore did not participate
in propulsion or manual muscle testing; however, they did complete
fatigue and accelerometer testing. In addition, wrist accelerometer
malfunction occurred in 1 IG and 1 CG participant, reducing the n
value to 8 for the IG and 4 for the CG (see tables 1-5).
Wrist accelerometer
Wrist accelerometer data are presented in table 2, which includes
mean SD values, percent change, and effect size. A statistically
significant group-by-time interaction was not found for activity
counts at the wrist (F1,10Z.217, PZ. 651, partial h2Z.021).
However, the IG displayed a larger percent increase than did the
CG (13.3% vs 6%).
Wheelchair propulsion
Propulsion metrics are presented in table 3, which includes mean
SD values and effect sizes. The IG demonstrated reduced braking
torque (F1,9Z16.8, PZ.003, h2Z.65) and stroke frequency
(F1,9Z3.4, PZ.09, h2Z.27) (approaching significance), with large
effect sizes compared with the CG from baseline to follow-up.
I.M. Rice et al
Table 2
Group
Baseline
3mo
% Change
Cohens d*
Effect Size
CG (nZ4)
IG (nZ8)
923,499.3475,384.4
980,428.9547,676.5
979,454.1639,999.5
1,111,080.1510,500.4
6.0[
13.3[
.14
Approaching small
NOTE. Values are mean SD or as otherwise indicated. The wrist accelerometer used was an ActiGraph model GT3X accelerometer.
Abbreviation: [, increase.
* Cohens d calculated mean change/pooled SD at baseline (range: 0.2 small, 0.5 moderate, 0.8 large).
Fatigue
FSS results are presented in table 5. There was a group-by-time
interaction for fatigue that approached statistical significance
with a large effect size (F1,12Z4.0, PZ.068, partial h2Z.25).
Safety/feasibility
IG participants were asked to describe their experience with the
ICON wheelchairs, and no adverse events were reported. IG
members reported that the ICON wheelchairs were lightweight
and comfortable, made mobility easier, and enabled them to
achieve and maintain speed. However, those performing standing
pivot transfers reported that the fixed footplate interfered with
standing. Swing-away footrests were their preference. Those who
performed sitting pivot transfers were unaffected. In addition,
some found the nonfolding frame and antitippers interfered with
car transport, making them less willing to travel. Also, some reported difficulties managing the hideaway locking brakes.
Table 3
Discussion
The purpose of this study was to evaluate the feasibility, safety, and
efficacy of a multifactorial lifestyle PA intervention for persons
with severe MS. We believe this to be the first experimental attempt
to examine an intervention for increased PA in this population.
Despite the preliminary nature of the study, intervention outcomes
were encouraging and may offer insights into the design of methods
to improve PA in a population where research is scarce.
The current study design did not allow for the determination of
which interventional component (optimization, training, behavioral
intervention) led to improvements, only the systems influence as a
whole, which is a limitation. However, as a preliminary study,
safety was a primary concern, where providing an extremely
responsive wheelchair to novice users without training/support in
order to separate the influence of the behavioral intervention or the
ICON was deemed unnecessarily risky. Instead, our goal was to
deliver a balanced approach offering IG subjects more supportive
conditions compared with a CG receiving the standard of care. It
was our intention to learn from participants reactions to improve
the study design for future, sufficiently powered investigations.
Consistent with our hypothesis, the intervention was well tolerated and no adverse events occurred. Additionally, moderate to large
effects sizes were observed, signifying favorable changes in aspects
of propulsion technique, upper extremity strength, and trends toward
reduced fatigue. Because fatigue has been cited as a primary factor
precluding individuals with MS from propulsion,31 this trend was
encouraging. Although strength measures should be interpreted
cautiously, the strength increase observed in the pectoralis major
may be of interest because it has been identified as both a primary
contributor to propulsion and as a muscle specifically shown to fatigue in some wheelchair users with MS during propulsion.32
Fundamental to our intervention was use of a custom-fit,
ultralightweight high-performance wheelchair, intended to
maximize ease of propulsion. Consistent with RESNAs recommendations, each ICON was customized to participants needs
while preserving its lightweight.17 Our IG participants learned to
IG (nZ9)
Performance Variables
Baseline
3mo
Baseline
3mo
Cohens d
Effect Size
37.710.4
32.41.3
1.00.1
7.33.3
54.611.2
38.96.8
1.00.1
8.13.4
46.120.0
43.916.3
0.80.1*
5.61.9y
45.812.9
46.215.1
0.790.2*
2.91.1y
1.04
0.36
0.1
0.73
Large
Small/moderate
Small
Moderate/large
NOTE. Values are mean SD or as otherwise indicated. Mean SD values are based on repeated-measures multivariate analysis of variance. Target
speed condition 0.5m/s.
* P<.09.
y
P<.0125.
www.archives-pmr.org
IG (nZ9)
Muscle Group
Base
3mo
% Change
Base
3mo
% Change
Cohens d*
Effect Size
Anterior deltoid
Middle deltoid
Latissimus dorsi
Pectoralis major
Triceps
Biceps
23.15.4
24.41.3
23.95.1
16.04.8
22.90.3
24.13.3
23.47.2
24.07.5
23.611.0
14.47.0
24.63.3
25.910.2
1.2 [
1.6 Y
1.2 Y
10.0 Y
7.4 [
7.4 [
19.73.3
18.63.3
22.24.3
12.52.5
24.34.3
25.66.5
22.24.4
22.24.4y
25.25.7
14.22.9z
21.92.6
26.55.5
2.5 [
19.3 [
13.0 [
13.6 [
9.8 Y
3.5 [
0.5
1.2
0.5
0.86
0.23
0.17
Moderate
Large
Moderate
Large
Small
Small
NOTE. Values are mean SD or as otherwise indicated. All mean SD values are based on mixed analysis of variance. Upper extremity muscle strength
was determined using the micro FET 2 wireless digital handheld dynamometer.
Abbreviations: [, increase; Y, decrease.
* Cohens d calculated mean change/pooled SD at baseline (range: 0.2 small, 0.5 moderate, 0.8 large).
y
P<.09.
z
P<.0125.
Table 5
Baseline
3mo
CG (nZ5)
IG (nZ9)
CG (nZ5)
IG (nZ9)
Cohens
dy
Effect
Size
5.21.5
5.71.2z
5.60.8
4.61.9z
1.15
Large
www.archives-pmr.org
Study limitations
As the current pilot study was a first step, inherent limitations
exist. The primary limitation of the current study is evident in the
use of a small sample size to examine numerous outcome measures. Because this was an early-phase study, the importance of
effect sizes cannot be overstated. A multisite design or the ability
to test remotely may increase enrollment in future studies.
Another limitation is evident in our lack of knowledge regarding
participants usage of their own wheelchairs because only the
ICON wheelchairs were instrumented. We plan to monitor multiple mobility devices in the future. Additionally, these results may
not generalize to all nonambulatory persons with MS because our
participants possessed a minimum level of upper limb strength.
The extent to which others with less strength could benefit from a
similar intervention is unclear and warrants investigation. In
addition, wheelchair propulsion measures were recorded at a
target speed during level treadmill propulsion that may not
represent users technique in the community. Finally, data
collection occurred over 10 months in central Illinois where the
weather may have influenced participants activity levels
differently.
Conclusions
Preliminary findings suggest that a PA intervention based on
wheelchair optimization, training, and a behavioral intervention is
feasible for some individuals with MS and may produce secondary benefits in strength, fatigue, and propulsion technique.
Both groups increased PA levels, with the IG showing a larger
percent change; however, differences were not statistically significant.
Suppliers
a. ICON A1 wheelchair; Icon Wheelchairs, Inc.
b. External contoured aluminum back support; Accessible Designs, Inc.
c. Varilite seat cushions; Varilite.
d. SHR100 portable triaxial accelerometer; Autonomous
Innovations.
e. SmartWheels; Out-Front.
f. ActiGraph model GT3X accelerometer; Actigraph Corp.
g. Micro FET 2 wireless digital handheld dynamometer; HOGGAN Scientific, LLC.
h. SPSS version 22; SPSS Inc.
Keywords
Fatigue; Motor activity; Multiple sclerosis; Rehabilitation; Quality
of life; Wheelchairs
Corresponding author
Ian M. Rice, PhD, Department of Kinesiology and Community
Health, University of Illinois at Urbana-Champaign, 332 Freer
Hall, Urbana, IL 61801. E-mail address: ianrice@illinois.edu.
I.M. Rice et al
References
1. Motl RW. Lifestyle physical activity in persons with multiple sclerosis: the new kid on the MS block. Mult Scler 2014;20:1025-9.
2. Bouchard C, Shephard RJ. Physical activity, fitness and health: the
model and key concepts. Champaign: Human Kinetics; 1994.
3. Dunn AL, Andersen RE, Jakicic JM. Lifestyle physical activity interventions. History, short- and long-term effects, and recommendations. Am J Prev Med 1998;15:398-412.
4. Motl RW, Sandroff BM. Objective monitoring of physical activity
behavior in multiple sclerosis. Phys Ther Rev 2010;15:204-11.
5. Motl RW, Fernhall B, McAuley E, Cutter G. Physical activity and selfreported cardiovascular comorbidities in persons with multiple sclerosis: evidence from a cross-sectional analysis. Neuroepidemiology
2011;36:83-191.
6. Ranadive SM, Yan H, Weikert M, et al. Vascular dysfunction and
physical activity in multiple sclerosis. Med Sci Sports Exerc 2012;44:
238-43.
7. Snook EM, Motl RW. Effect of exercise training on walking mobility
in multiple sclerosis: a meta-analysis. Neurorehabil Neural Repair
2009;23:108-16.
8. Sandroff BM, Pilutti LA, Dlugonski D, Motl RW. Physical activity and
information processing speed in persons with multiple sclerosis: a
prospective study. Ment Health Phys Act 2013;6:205-11.
9. Pilutti LA, Greenlee TA, Motl RW, Nickrent MS, Petruzzello SJ.
Effects of exercise training on fatigue in multiple sclerosis: a metaanalysis. Psychosom Med 2013;75:575-80.
10. Pilutti LA, Dlugonski D, Sandroff BM, Klaren R, Motl RW. Randomized controlled trial of a behavioral intervention targeting symptoms and physical activity in multiple sclerosis. Mult Scler 2014;20:
594-601.
11. Sandroff BM, Klaren RE, Pilutti LA, Dlugonski D, Benedict RH,
Motl RW. Randomized controlled trial of physical activity, cognition,
and walking in multiple sclerosis. J Neurol 2014;261:363-72.
12. Motl RW, Gosney JL. Effect of exercise training on quality of life in
multiple sclerosis: a meta-analysis. Mult Scler 2008;14:129-35.
13. Bombardier CH, Ehde DM, Gibbons LE, et al. Telephone-based
physical activity counseling for major depression in people with
multiple sclerosis. J Consult Clin Psychol 2013;81:89-99.
14. Plow M, Bethoux F, McDaniel C, McGlynn M, Marcus B. Randomized controlled pilot study of customized pamphlets to promote
physical activity and symptom self-management in women with
multiple sclerosis. Clin Rehabil 2014;28:139-48.
15. Motl RW, Arnett PA, Smith MM, Barwick FH, Ahlstrom B, Stover EJ.
Worsening of symptoms is associated with lower physical activity levels
in individuals with multiple sclerosis. Mult Scler 2008;14:140-2.
16. Marrie R, Horwitz R, Cutter G, Tyry T, Campagnolo D, Vollmer T.
High frequency of adverse health behaviors in multiple sclerosis. Mult
Scler 2009;15:105-13.
17. Rehabilitation Engineering and Assistive Technology Society of North
America. RESNA position on the application of ultralight manual
wheelchairs. Arlington; 2012.
18. Rice IM, Pohlig RT, Gallagher JD, Boninger ML. Handrim wheelchair
propulsion training effect on overground propulsion using biomechanical real-time visual feedback. Arch Phys Med Rehabil 2013;94:256-63.
19. Consortium for Spinal Cord Medicine. Preservation of upper limb
function following spinal cord injury: a clinical practice guideline for
health-care professionals. Washington (DC): Paralyzed Veterans of
America; 2005.
20. Bandura A. Health promotion by social cognitive means. Health Educ
Behav 2004;31:143-64.
21. Sonenblum SE, Sprigle S, Lopez RA. Manual wheelchair use: bouts of
mobility in everyday life. Rehabil Res Pract 2012;2012:753165.
22. Learmonth YC, Kinnett-Hopkins D, Rice IM, Dysterheft JL, Motl RW.
Accelerometer output and its association with energy expenditure
during manual wheelchair propulsion. Spinal Cord. 2015 Mar 17.
[Epub ahead of print]
www.archives-pmr.org
www.archives-pmr.org
9
32. Fay B, Boninger ML, Ambrosio F, Cooper RA. Aspects of fatigue in
multiple sclerosis during manual wheelchair propulsion. In: Proceedings of the 25th Annual lnternational Conference of the IEEE
EMBS; September 17-21, 2003; Edmonton, Alberta, Canada.
33. Tolerico ML, Ding D, Cooper RA, et al. Assessing mobility characteristics and activity levels of manual wheelchair users. J Rehabil Res
Dev 2007;44:561-71.
34. Verza R, Battaglia MA, Uccelli MM. Manual wheelchair propulsion
pattern use by people with multiple sclerosis. Disabil Rehabil Assist
Technol 2010;5:314-7.
35. Beekman CE, Miller-Porter L, Schoneberger M. Energy cost of propulsion in standard and ultralight wheelchairs in people with spinal
cord injuries. Phys Ther 1999;79:146-58.
36. Ambrosio F, Boninger ML, Fitzgerald SG, Hubbard SL, Schwid SR,
Cooper RA. Comparison of mobility device delivery within Department of Veterans Affairs for individuals with multiple sclerosis versus
spinal cord injury. J Rehabil Res Dev 2007;44:693-701.
37. Dlugonski D, Motl RW, McAuley E. Increasing physical activity in
multiple sclerosis: replicating Internet intervention effects using
objective and self-report outcomes. J Rehabil Res Dev 2011;48:
1129-36.
38. Motl RW, Dlugonski D, Wojcicki TR, McAuley E, Mohr DC. Internet
intervention for increasing physical activity in persons with multiple
sclerosis. Mult Scler 2011;17:116-28.
39. Evers KJ, Karnilowicz W. Patient attitude as a function of disease state
in multiple sclerosis. Soc Sci Med 1996;43:1245-51.